PMID- 33224757 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201124 IS - 2223-3652 (Print) IS - 2223-3660 (Electronic) IS - 2223-3652 (Linking) VI - 10 IP - 5 DP - 2020 Oct TI - A case of acute myelogenous leukemia characterized by arterial and venous thrombosis. PG - 1332-1340 LID - 10.21037/cdt-20-486 [doi] AB - Acute myelogenous leukemia (AML) is a malignant disease of the hematopoietic system, characterized by features of bone marrow insufficiency and organ infiltration by leukemic cells. Venous thrombosis in AML patients is uncommon, compared to bleeding; therefore in patients with AML, simultaneous occurrence of venous and arterial thrombosis is a rather rare presentation. We reported an unusual case of anti-phospholipid antibody syndrome secondary to AML characterized by venous and arterial thrombosis. A 70-year-old man with deep venous thrombosis (DVT) of the left leg confirmed by Doppler was seen in our clinic. During treatment with a Vitamin K antagonist (3 mg daily of Warfarin) and a low molecular weight heparin (LMWH), he developed an acute pulmonary embolism and an acute inferior wall ST elevation myocardial infarction (STEMI), a result of right coronary artery embolism. His full blood count showed leukocytosis and thrombocytopenia. Lupus anticoagulant and anti-cardiolipin antibodies were positive. A bone marrow aspirate test showed results consistent with AML (FAB class M1). A diagnosis of antiphospholipid antibody syndrome secondary to AML characterized by coronary artery embolism, pulmonary embolism and left leg DVT was eventually established. He received anticoagulation with a low dose of warfarin after refusing chemotherapy. He however died of cerebral hemorrhage despite the fact that the INR was in the normal therapeutic range. It is challenging to anticoagulated AML patients complicated by multiple vascular thromboses and thrombocytopenia. CI - 2020 Cardiovascular Diagnosis and Therapy. All rights reserved. FAU - Liang, Huasheng AU - Liang H AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. FAU - Ba, Mingchuan AU - Ba M AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. FAU - Li, Chen AU - Li C AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. FAU - Li, Haoping AU - Li H AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. FAU - Guo, Zhiqiang AU - Guo Z AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. FAU - He, Pengcheng AU - He P AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. FAU - Lin, Chunying AU - Lin C AD - Department of Cardiology, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, China. LA - eng PT - Case Reports PL - China TA - Cardiovasc Diagn Ther JT - Cardiovascular diagnosis and therapy JID - 101601613 PMC - PMC7666938 OTO - NOTNLM OT - Acute myelogenous leukemia (AML) OT - acute myocardial infarction OT - antiphospholipid antibody syndrome OT - deep venous thrombosis (DVT) OT - pulmonary embolism COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/cdt-20-486). The authors have no conflicts of interest to declare. EDAT- 2020/11/24 06:00 MHDA- 2020/11/24 06:01 PMCR- 2020/10/01 CRDT- 2020/11/23 05:40 PHST- 2020/11/23 05:40 [entrez] PHST- 2020/11/24 06:00 [pubmed] PHST- 2020/11/24 06:01 [medline] PHST- 2020/10/01 00:00 [pmc-release] AID - cdt-10-05-1332 [pii] AID - 10.21037/cdt-20-486 [doi] PST - ppublish SO - Cardiovasc Diagn Ther. 2020 Oct;10(5):1332-1340. doi: 10.21037/cdt-20-486.